Inventor · disambiguated record
John Lee
Also filed as: LEE JOHN · LEE JOHN C · LEE JR JOHN
35 granted patents·30 pending applications·4,304 citations·filing 1986–2024
98Inventor score
Files withSMITHKLINE BEECHAM CORP15KYVERNA THERAPEUTICS INC10SUTRO BIOPHARMA INC10STRYKER CORP9LEE JOHN C7
Top patents by PatentIndex Score
65 records- 0198US6645989B2CompoundsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Nov 11, 2003·91 cites·13 claims
- 0298US5948428ACompositions and therapeutic methods using morphogenic proteins and stimulatory factorsSTRYKER CORP·Filed 1996·Granted Sep 7, 1999·342 cites·78 claims
- 0398US5656644APyridyl imidazolesSMITHKLINE BEECHAM CORP·Filed 1994·Granted Aug 12, 1997·224 cites·13 claims
- 0497US6268370B1CompoundsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Jul 31, 2001·106 cites·12 claims
- 0597US6048964ACompositions and therapeutic methods using morphogenic proteins and stimulatory factorsSTRYKER CORP·Filed 1995·Granted Apr 11, 2000·227 cites·21 claims
- 0697US5916870ACompositions and therapeutic methods using morphogenic proteins and stimulatory factorsSTRYKER CORP·Filed 1998·Granted Jun 29, 1999·302 cites·42 claims
- 0797US5854207ACompositions and therapeutic methods using morphogenic proteins and stimulatory factorsSTRYKER CORP·Filed 1998·Granted Dec 29, 1998·257 cites·28 claims
- 0896US5686455AImidazole derivatives and their use as cytokine inhibitorsSMITHKLINE BEECHAM CORP·Filed 1993·Granted Nov 11, 1997·205 cites·14 claims
- 0995US6050990AMethods and devices for inhibiting hair growth and related skin treatmentsTHERMOLASE CORP·Filed 1997·Granted Apr 18, 2000·1.9k cites·9 claims
- 1093US5916891APyrimidinyl imidazolesSMITHKLINE BEECHAM CORP·Filed 1995·Granted Jun 29, 1999·63 cites·19 claims
- 1192US11254721B2GIPR-agonist compoundsLILLY CO ELI·Filed 2020·Granted Feb 22, 2022·5 cites·3 claims
- 1292US5871934AScreening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteinsSMITHKLINE BEECHAM CORP·Filed 1994·Granted Feb 16, 1999·96 cites·7 claims
- 1392US5777097AOligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding proteinSMITHKLINE BEECHAM CORP·Filed 1995·Granted Jul 7, 1998·96 cites·1 claims
- 1491US11897926B2GIPR-agonist compoundsLILLY CO ELI·Filed 2022·Granted Feb 13, 2024·3 cites·4 claims
- 1587US5955366APolynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteinsSMITHKLINE BEECHAM CORP·Filed 1997·Granted Sep 21, 1999·46 cites·25 claims
- 1686US5783664ACytokine suppressive anit-inflammatory drug binding proteinsSMITHKLINE BEECHAM CORP·Filed 1994·Granted Jul 21, 1998·86 cites·6 claims
- 1785US5317019AInhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophagesSMITHKLINE BEECHAM CORP·Filed 1990·Granted May 31, 1994·70 cites·4 claims
- 1885US4794114AInhibition of interleukin-1 production by monocytes and/or macrophagesSMITHKLINE BECKMAN CORP·Filed 1987·Granted Dec 27, 1988·37 cites·20 claims
- 1983US6696410B1Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptorsSTRYKER CORP·Filed 2000·Granted Feb 24, 2004·11 cites·27 claims
- 2081US11446357B2Method for treating disease using FOXP3+CD4+ T cellsKYVERNA THERAPEUTICS INC·Filed 2021·Granted Sep 20, 2022·1 cites·15 claims
- 2177US5969184AAmide compoundsSMITHKLINE BEECHAM CORP·Filed 1997·Granted Oct 19, 1999·31 cites·8 claims
- 2274US7026292B1Compositions and therapeutic methods using morphogenic proteins and stimulatory factorsSTRYKER CORP·Filed 1999·Granted Apr 11, 2006·36 cites·7 claims
- 2373US2024218031A1Gipr-agonist compoundsLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2471US12115210B2Long acting amylin receptor agonists and uses thereofLILLY CO ELI·Filed 2022·Granted Oct 15, 2024·0 cites·20 claims
- 2566US2007191276A1Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptorsLEE JOHN C·Filed 2007·Application pending·0 cites
- 2664US2023104151A1A method for treating disease using foxp3+cd4+ t cellsKYVERNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2764US2022106401A1ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EpCAM ANTIBODIESSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2864US2007249535A1Methods for treating bone tumorsLEE JOHN C·Filed 2007·Application pending·0 cites
- 2963US2004138128A1Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptorsSTRYKER CORP·Filed 2004·Application pending·0 cites
- 3062US11879003B2Methods for increasing T-cell functionKYVERNA THERAPEUTICS INC·Filed 2022·Granted Jan 23, 2024·0 cites·24 claims
- 3162US2021403558A1Anti-tim-3 antibodies, compositions comprising anti-tim-3 antibodies and methods of making and using anti-tim-3 antibodiesSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3261US6361773B1Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteinsSMITHKLINE BEECHAM CORP·Filed 1997·Granted Mar 26, 2002·21 cites·4 claims
- 3361US2023330141A1Methods of producing t regulatory cells, methods of transducing t cells, and uses of the sameKYVERNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3460US2022169687A1Method for treating disease using foxp3+cd4+ t cellsKYVERNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3560US2021107981A1Anti-pd-1 antibodies, compositions comprising anti-pd-1 antibodies and methods of using anti-pd-1 antibodiesSUTRO BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3660US2006111298A1Compositions and therapeutic methods using morphogenic proteins and stimulatory factorsLEE JOHN C·Filed 2006·Application pending·0 cites
- 3760US2024158459A1Methods for increasing t-cell functionKYVERNA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3857US2024261405A1Methods and compositions for treating autoimmune diseaseKYVERNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3956US2005152883A1Compositions and methods for ligament growth and repairFiled 2004·Application pending·0 cites
- 4055US10822414B2Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodiesSUTRO BIOPHARMA INC·Filed 2015·Granted Nov 3, 2020·0 cites·35 claims
- 4155US2022031751A1Methods of producing t regulatory cells, methods of transducing t cells, and uses of the sameKYVERNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4254US2007066525A1Compositions and therapeutic methods using morphogenic proteinsLEE JOHN C·Filed 2006·Application pending·0 cites
- 4354US2006035268A1Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elementsYEH LEE-CHUAN C·Filed 2005·Application pending·0 cites
- 4453US6987021B2Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elementsSTRYKER CORP·Filed 2002·Granted Jan 17, 2006·0 cites·13 claims
- 4553US6150557ACompoundsSMITHKLINE BEECHAM CORP·Filed 1998·Granted Nov 21, 2000·8 cites·16 claims
- 4653US4780470AInhibition of interleukin-1 by monocytes and/or macrophagesSMITHKLINE BECKMAN CORP·Filed 1986·Granted Oct 25, 1988·16 cites·12 claims
- 4752US4778806AInhibition of interleukin-1 production by monocytes and/or macrophagesSMITHKLINE BECKMAN CORP·Filed 1986·Granted Oct 18, 1988·15 cites·10 claims
- 4852US2002188122A1Novel compoundsSMITHKLINE BEECHAM CORP·Filed 2001·Application pending·0 cites
- 4950US11098131B2Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodiesSUTRO BIOPHARMA INC·Filed 2016·Granted Aug 24, 2021·0 cites·29 claims
- 5050US11014983B2Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodiesSUTRO BIOPHARMA INC·Filed 2016·Granted May 25, 2021·0 cites·27 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →